BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li X, Dean DC, Cote GM, Zou L, Hornicek FJ, Yu S, Duan Z. Inhibition of ATR-Chk1 signaling blocks DNA double-strand-break repair and induces cytoplasmic vacuolization in metastatic osteosarcoma. Ther Adv Med Oncol 2020;12:1758835920956900. [PMID: 32973933 DOI: 10.1177/1758835920956900] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Liu X, Wang Z, Liu M, Zhi F, Wang P, Liu X, Yu S, Liu B, Jiang Y, Bu D. Identification of LTF as a Prognostic Biomarker for Osteosarcoma. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/4656661] [Reference Citation Analysis]
2 Chen W, Lin Y, Huang J, Yan Z, Cao H. A novel risk score model based on glycolysis-related genes and a prognostic model for predicting overall survival of osteosarcoma patients. J Orthop Res 2022. [PMID: 34997639 DOI: 10.1002/jor.25259] [Reference Citation Analysis]
3 Alemi F, Malakoti F, Vaghari-Tabari M, Soleimanpour J, Shabestani N, Sadigh AR, Khelghati N, Asemi Z, Ahmadi Y, Yousefi B. DNA damage response signaling pathways as important targets for combination therapy and chemotherapy sensitization in osteosarcoma. J Cell Physiol 2022. [PMID: 35383920 DOI: 10.1002/jcp.30721] [Reference Citation Analysis]
4 Bowler E, Skwarska A, Wilson JD, Ramachandran S, Bolland H, Easton A, Ostheimer C, Hwang MS, Leszczynska KB, Conway SJ, Hammond EM. Pharmacological Inhibition of ATR Can Block Autophagy through an ATR-Independent Mechanism. iScience 2020;23:101668. [PMID: 33134898 DOI: 10.1016/j.isci.2020.101668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Gill J, Gorlick R. Advancing therapy for osteosarcoma. Nat Rev Clin Oncol 2021. [PMID: 34131316 DOI: 10.1038/s41571-021-00519-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sadoughi F, Maleki Dana P, Asemi Z, Yousefi B. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications. DNA Repair (Amst) 2021;102:103105. [PMID: 33836418 DOI: 10.1016/j.dnarep.2021.103105] [Reference Citation Analysis]
7 Hattinger CM, Patrizio MP, Fantoni L, Casotti C, Riganti C, Serra M. Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers (Basel) 2021;13:2878. [PMID: 34207685 DOI: 10.3390/cancers13122878] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]